Novartis calls off 3 Beovu trials testing more frequent dosing on concerns of vision-threatening side effect

Novartis calls off 3 Beovu trials testing more frequent dosing on concerns of vision-threatening side effect
aliu
Tue, 06/01/2021 – 11:20